GPC shores up kinase portfolio with Axxima buy
German cancer drug company GPC Biotech has agreed to buy the material assets of Munich-based kinase specialist Axxima Pharmaceuticals in a cash-neutral transaction for €13.7m.
German cancer drug company GPC Biotech has agreed to buy the material assets of Munich-based kinase specialist Axxima Pharmaceuticals in a cash-neutral transaction for €13.7m.
US company Biotrove says its mass spectrometry-based high-throughput screening (HTS) system, RapidFire Lead Discovery, has been used to screen more than a million individual samples over the last 12 months.
R&D productivity is currently in a period of decline, with the number of new medicines being introduced to the market declining in the face of increasing R&D budgets. However, the emergence of genomics-derived drugs is expected to enter the...
Costs rises for raw materials and energy push Philadelphia-based FMC BioPolymer to hike up prices for its cellulose gel range.
A module has been designed for Niro's Courtoy MODUL tablet press that allows it to keep operating while the cleaning cycle runs.
GE Healthcare has launched two new products designed to meet growing industry needs for the purification of monoclonal antibodies, one of the fastest growing drug classes in the drug industry.
Roche has started the roll-out its colorectal cancer treatment Avastin (bevacizumab) - the first drug to reach the market that works by inhibiting blood vessel formation in tumours - in Europe.
Efforts by Pakistan to build a pharmaceutical sector to rival that of neighbouring India are being undermined by regulatory interference, according to representatives of the domestic drug industry.
A group of US researchers claim to have identified a fundamental mechanism that may facilitate the design of safer and more efficacious topical drug delivery systems, reports Phil Taylor.